Logo
Health Tech Nerds
Search
Subscribe
Sign In
Home
Community
About
Sponsor

Industry Expert Knowledge

Topic Analysis

Company Research

Community Brain Trust

Weekly Health Tech Reads

The Library

Weekly Health Policy Briefing


Rachel Wilson, Co-founder and COO of Bluebird Kids Health on pediatric value-based care

Oct 20, 2025

•

33 min read

Rachel Wilson, Co-founder and COO of Bluebird Kids Health on pediatric value-based care

The challenges and opportunities of Medicaid Managed Care for children, build versus buy decisions, and the opportunity for generational returns by investing in children’s health.

Martin Cech
Martin Cech
Fortuna Health: Initiation of Coverage Report

Oct 8, 2025

•

11 min read

Fortuna Health: Initiation of Coverage Report

Medicaid eligibility and enrollment support at a critical moment for payers, providers, and patients.

Martin Cech
Martin Cech
Mike Suiters, CEO of Positive Development, on choices for Autism Spectrum Disorder therapy

Sep 23, 2025

•

26 min read

Mike Suiters, CEO of Positive Development, on choices for Autism Spectrum Disorder therapy

A discussion with Mike Suiters on Positive Development's pioneering of developmental therapy and why Autism Spectrum Disorder therapy has gotten so expensive

Martin Cech
Kevin O'Leary
Martin Cech, Kevin O'Leary
Oscar Health's 2024 Investor Day
LockSimple

Jun 14, 2024

•

33 min read

Oscar Health's 2024 Investor Day

A review of the key trends from the recent investor day

Kevin O'Leary
Kevin O'Leary
Takeaways from BofA's Healthcare Conference
LockSimple

May 17, 2024

•

33 min read

Takeaways from BofA's Healthcare Conference

Summarizing takeaways from Alignment, Astrana, Clover, CVS, HCA, Humana, Oscar, Tenet, and UHG

Kevin O'Leary
Kevin O'Leary
JPMorgan 2024 Review
LockSimple

Jan 19, 2024

•

29 min read

JPMorgan 2024 Review

Top takeaways from public company presentations at JPMorgan Healthcare Conference 2024.

Kevin O'Leary
Kevin O'Leary
Our Reflections on CVS / Oak Street
LockSimple

Feb 14, 2023

•

43 min read

Our Reflections on CVS / Oak Street

Diving into some of the key questions posed by the deal - is the MA Golden Age over, Oak's J-Curve, and CVS's broader strategy

Kevin O'Leary
Kevin O'Leary
Case Study: Revisiting Bright’s Strategy Circa 2016
LockSimple

Oct 19, 2022

•

33 min read

Case Study: Revisiting Bright’s Strategy Circa 2016

Looking back at Bright's early strategy to understand whether its individual exchange business was always doomed from the start

Kevin O'Leary
Kevin O'Leary
Nerding Out with Ro's CEO: Our Reflections
LockSimple

Oct 11, 2022

•

18 min read

Nerding Out with Ro's CEO: Our Reflections

Our reflections on a conversation with Ro's CEO, Zachariah Reitano, about all things Ro

Health Tech Nerds
Health Tech Nerds
Lessons from +Oscar's Challenges
LockSimple

Sep 27, 2022

•

14 min read

Lessons from +Oscar's Challenges

Perspective on the commercial challenges that have plagued +Oscar's launch and learning lessons for others

Kevin O'Leary
Kevin O'Leary
Humana's 2022 Investor Day Review
LockSimple

Sep 20, 2022

•

34 min read

Humana's 2022 Investor Day Review

A deep dive into Humana’s 2022 investor day and what’s in store for the MA insurer.

Kevin O'Leary
Kevin O'Leary
Amazon, CVS, and UHG: Exploring Signify's Significance
LockSimple

Aug 28, 2022

•

9 min read

Amazon, CVS, and UHG: Exploring Signify's Significance

Looking at the strategic implications of Signify for Amazon, CVS, and UHG

Kevin O'Leary
Kevin O'Leary
Q2 Earnings Updates: agilon, Alignment, Amwell, CVS, & Oak Street
LockSimple

Aug 7, 2022

•

19 min read

Q2 Earnings Updates: agilon, Alignment, Amwell, CVS, & Oak Street

Our key strategic takeaways from earnings calls

Kevin O'Leary
Kevin O'Leary
Q2 Earnings Updates: Centene, Humana, & Teladoc
LockSimple

Jul 31, 2022

•

16 min read

Q2 Earnings Updates: Centene, Humana, & Teladoc

A summary of our key takeaways from earnings calls this week

Kevin O'Leary
Kevin O'Leary
The Amazon / One Medical Deal
LockSimple

Jul 24, 2022

•

22 min read

The Amazon / One Medical Deal

Our perspective on the key strategic questions posed by Amazon's announced $3.9 billion acquisition of One Medical

Kevin O'Leary
Kevin O'Leary
UHG's Q2 2022 Earnings Review
LockSimple

Jul 24, 2022

•

12 min read

UHG's Q2 2022 Earnings Review

A look at our takeways from UHG's earnings call - senior care priorities, a provider acquisition long game, unclear VBC metrics, & more

Kevin O'Leary
Kevin O'Leary
An Overview of Carbon Health
LockSimple

Jun 4, 2022

•

54 min read

An Overview of Carbon Health

Taking a look at Carbon Health's urgent care business & broader aspirations

Kevin O'Leary
Kevin O'Leary
Babylon's Investor Day
LockSimple

May 29, 2022

•

35 min read

Babylon's Investor Day

A review of Babylon's recent Investor Day

Kevin O'Leary
Kevin O'Leary
Oscar Health's 2022 Analyst Day
LockSimple

May 27, 2022

•

26 min read

Oscar Health's 2022 Analyst Day

A review of Oscar's analyst day and deep dive into the insurance + platform business

Kevin O'Leary
Kevin O'Leary
Clovers Q1 22 Earnings: Pivoting to an MSO
LockSimple

May 15, 2022

•

21 min read

Clovers Q1 22 Earnings: Pivoting to an MSO

A look at Clover's Q1 2022 earnings announcement and how it appears to be pivoting to an MSO-like play

Kevin O'Leary
Kevin O'Leary
Earnings Week in Review | 5/13/22 | Babylon, Oscar, Privia
LockSimple

May 13, 2022

•

17 min read

Earnings Week in Review | 5/13/22 | Babylon, Oscar, Privia

Discussing our key takeaways from notable earnings sessions this week - Babylon, Oscar, and Privia

Kevin O'Leary
Kevin O'Leary
Devoted Health: Checking in
LockSimple

May 1, 2022

•

22 min read

Devoted Health: Checking in

Taking a look at what we know about Devoted Health

Kevin O'Leary
Kevin O'Leary
Anthem's Q1 2022 Earnings Results
LockSimple

Apr 24, 2022

•

7 min read

Anthem's Q1 2022 Earnings Results

Our perspective on Anthem's Q1 2022 earnings call.

Kevin O'Leary
Kevin O'Leary
Perspective on UHG's Q1 2022 Earnings Call
LockSimple

Apr 24, 2022

•

10 min read

Perspective on UHG's Q1 2022 Earnings Call

Taking a look at UHG's Q1 2022 results

Kevin O'Leary
Kevin O'Leary
A Conversation with Cerebral's CMO, Dr. David Mou

Apr 12, 2022

•

4 min read

A Conversation with Cerebral's CMO, Dr. David Mou

A conversation with Cerebral's CMO discussing their model and the mental health landscape more broadly

Kevin O'Leary
Kevin O'Leary
Load more

Health Tech Nerds

Insightful content and vibrant community trusted by over 30,000 healthcare leaders and innovators.

About | FAQs